NCT00832364 Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis Status WITHDRAWN Phase PHASE4
NCT00796211 A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00747032 To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis Status WITHDRAWN Phase PHASE3
NCT00746434 A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis Status WITHDRAWN Phase PHASE2
NCT00733954 Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT00708851 NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study Status COMPLETED Phase NA
NCT00691964 Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT00669916 A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis Status COMPLETED Phase PHASE1/PHASE2
NCT00663052 Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis Status COMPLETED Phase PHASE4
NCT00658606 Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects Status COMPLETED Phase PHASE4
NCT00608777 Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva) Status TERMINATED Phase PHASE4
NCT00581100 Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT00570986 A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT00555646 Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis Status TERMINATED Phase PHASE2
NCT00540618 A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis Status COMPLETED Phase PHASE2
NCT00437255 Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis Status COMPLETED Phase PHASE4
NCT00402818 RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization Status TERMINATED Phase N/A
NCT00382512 A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis Status COMPLETED Phase PHASE1